David A Leiby
Overview
Explore the profile of David A Leiby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drews S, Kjemtrup A, Krause P, Lambert G, Leiby D, Lewin A, et al.
J Clin Microbiol
. 2023 Sep;
61(10):e0126822.
PMID: 37750699
spp. are tick-borne parasites with a global distribution and diversity of vertebrate hosts. Over the next several decades, climate change is expected to impact humans, vectors, and vertebrate hosts and...
2.
Drews S, Wendel S, Leiby D, Tonnetti L, Ushiro-Lumb I, OBrien S, et al.
Transfusion
. 2022 Dec;
63(3):638-645.
PMID: 36565251
No abstract available.
3.
Crowder L, Wendel S, Bloch E, OBrien S, Delage G, Sauleda S, et al.
Vox Sang
. 2021 Jun;
117(1):58-63.
PMID: 34111301
Background And Objectives: Chagas disease, caused by Trypanosoma cruzi, is endemic to Mexico, Central and South America. While initially limited to the Americas, emigration of infected persons triggered geographically broader...
4.
Mohan K, Leiby D
Transfusion
. 2020 Mar;
60(7):1624-1632.
PMID: 32208532
Tick-borne agents of disease continue to emerge and subsequently expand their geographic distribution. The threat to blood safety by tick-borne agents is ever increasing and requires constant surveillance concomitant with...
5.
Wagner S, Leiby D, Roback J
Hematol Oncol Clin North Am
. 2019 Aug;
33(5):739-748.
PMID: 31466601
Despite measures to mitigate risk of transfusion-transmitted infections, emerging agents contribute to morbidity and mortality. We outline the epidemiology, risk mitigation strategies, and impact on patients for Zika virus, bacteria,...
6.
OBrien S, Ward S, Gallian P, Fabra C, Pillonel J, Kitchen A, et al.
Blood Transfus
. 2019 Mar;
17(2):94-102.
PMID: 30865584
Background: In non-endemic countries, malaria risk is addressed by selectively testing or deferring at-risk donors. These policy decisions were made using a variety of decision-making frameworks prior to the development...
7.
Leiby D, OBrien S, Wendel S, Nguyen M, Delage G, Devare S, et al.
Vox Sang
. 2018 Dec;
114(1):17-27.
PMID: 30523642
Background And Objectives: Globally, blood safety interventions have been successful in mitigating risk of the major transfusion-transmitted (TT) viruses. However, strategies that address risk from parasites are comparatively limited. TT...
8.
Nelson K, Ness P, Leiby D
Am J Trop Med Hyg
. 2017 May;
96(3):762.
PMID: 28471741
No abstract available.
9.
Leiby D, Nguyen M, Proctor M, Townsend R, Stramer S
Transfusion
. 2017 Mar;
57(6):1426-1432.
PMID: 28295355
Background: Trypanosoma cruzi is endemic to the Americas where it demonstrates multiple lineages over a vast geographic range (i.e., United States to Argentina). These lineages possess divergent geographic and biologic...
10.
Kuehnert M, Basavaraju S, Moseley R, Pate L, Galel S, Williamson P, et al.
MMWR Morb Mortal Wkly Rep
. 2016 Jun;
65(24):627-8.
PMID: 27337368
Transfusion-transmitted infections have been documented for several arboviruses, including West Nile and dengue viruses (1). Zika virus, a flavivirus transmitted primarily by Aedes aegypti mosquitoes that has been identified as...